Product
Sapropterin Dihydrochloride
2 clinical trials
3 indications
Indication
Peripheral Artery DiseaseIndication
Peripheric Vascular EnfermedadIndication
Pancreatic Adenocarcinoma MetastaticClinical trial
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow, Mitochondrial Function and Leg Performance in Patients With Peripheral Artery DiseaseStatus: Withdrawn, Estimated PCD: 2019-07-01
Clinical trial
The Efficacy and Safety of PD-1 Antibody Combined With Sapropterin Dihydrochloride in Patients With Advanced Pancreatic Cancer Who Failed to Standard Treatment.Status: Recruiting, Estimated PCD: 2025-04-30